Abstract:Protein acetylation modifications play a central and pivotal role in a myriad of biological processes, spanning cellular metabolism, proliferation, differentiation, apoptosis, and beyond, by effectively reshaping protein structure and function. The metabolic state of cells is intricately connected to epigenetic modifications, which in turn influence chromatin status and gene expression patterns. Notably, pathological alterations in protein acetylation modifications are frequently observed in diseases such as metabolic syndrome, cardiovascular disorders, and cancer. Such abnormalities can result in altered protein properties and loss of function, which are closely associated with developing and progressing related diseases. In recent years, the advancement of precision medicine has highlighted the potential value of protein acetylation in disease diagnosis, treatment, and prevention. This review includes provocative and thought-provoking papers outlining recent breakthroughs in acetylation modifications as they relate to cardiovascular disease, mitochondrial metabolic regulation, liver health, neurological health, obesity, diabetes, and cancer. Additionally, it covers the molecular mechanisms and research challenges in understanding the role of acetylation in disease regulation. By summarizing novel targets and prognostic markers for the treatment of related diseases, we aim to contribute to the field. Furthermore, we discuss current hot topics in acetylation research related to health regulation, including N4-acetylcytidine and liquid-liquid phase separation. The primary objective of this review is to provide insights into the functional diversity and underlying mechanisms by which acetylation regulates proteins in disease contexts.

Deacylases—structure, function, and relationship to diseases

Mechanisms and functions of protein S-acylation

The molecular era of protein S-acylation: spotlight on structure, mechanisms, and dynamics

Regulation of T cell function by protein S-acylation

Recruitment, regulation, and release: Control of signaling enzyme localization and function by reversible S-acylation

Protein Acylation is a General Regulatory Mechanism in Biosynthetic Pathway of Acyl-CoA-Derived Natural Products

The Zinc-Dependent HDACs: Non-Histone Substrates and Catalytic Deacylation Beyond Deacetylation.

Acetylation in pathogenesis: Revealing emerging mechanisms and therapeutic prospects

Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design

Functions of Coenzyme A and Acyl-CoA in Post-Translational Modification and Human Disease

Acetyl-CoA Carboxylases and Diseases

The (patho)physiological roles of the individual deacylase activities of a sirtuin

The role of s-palmitoylation in neurological diseases: implication for zDHHC family

An acylated N-terminus and a conserved loop regulate the activity of the ABHD17 de-acylase

S-acylation of ATGL is required for lipid droplet homoeostasis in hepatocytes

A palmitoyl transferase chemical–genetic system to map ZDHHC-specific S -acylation

Mechanism and Function of Dhhc S-Acyltransferases

The structure of histone deacetylase 2 and its role in diseases

Progress in Structure, Function and Catalytic Reactions of Sialidase and Sialyltransferase

Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases

An outlook on protein S-acylation in plants: what are the next steps?